Furthermore, TREM-2 deficiency impairs the maturation of experimentally acquired cholesteatoma, which decreases proinflammatory cytokine and MMP secretion and diminishes osteoclast formation in vivo. The gene discussed is TREM2; the disease is cholesteatoma.